Evidence map›Paper›PMID 35214846›Full record

ArticlePlants (Basel, Switzerland)2022

Phytochemical Screening of

Majid Rasool Kamli, Abeer Abdullah M Sharaf, Jamal S M Sabir, Irfan A Rather

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 52 citations in OpenAlex.

  1. Plants (Basel, Switzerland) · 2026
    Review
  2. Rosemary (Iranian journal of basic medical sciences · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Deciphering Neuroprotective Effect ofCurrent drug targets · 2024
    Review
  13. Article
  14. Review
  15. Frontiers in pharmacology · 2022
    Article
  16. Evaluation of the Effectiveness of an Herbal Formulation ofJournal of research in pharmacy practice
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Majid Rasool KamliDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-0553-0046
Abeer Abdullah M SharafJeddah Regional Lab, The Saudi Ministry of Health, Jeddah 21482, Saudi Arabia.
Jamal S M SabirDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-4785-9894
Irfan A RatherDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-2752-0519
King Abdulaziz University · SAMinistry of Health · SA

Funding

King Abdulaziz University D-264-130-1440
6 · The paper itself

Abstract

The inhibition of acetylcholinesterase (AChE) by cholinergic agents has been promoted as a potent strategy for treating and managing cognitive decline disorders. A wide range of natural products has long been used as potential sources or formulations of cholinergic inhibitors. Therefore, this study aimed to evaluate different

Indexed as

acetylcholinesteraseAlzheimer’s diseasecarnosic acidmolecular dockingrosemaryrosmarinic acidRosmarinus officinalis

Identifiers

PMID35214846
PMCPMC8877369
OpenAlexW4213081635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.